116 related articles for article (PubMed ID: 31322913)
1. Comparison of 3T diffusion-weighted MRI and
Lee SY; Jee WH; Yoo IR; Jung JY; Im SA; Chung YG; Kang JH
Br J Radiol; 2019 Oct; 92(1102):20181051. PubMed ID: 31322913
[TBL] [Abstract][Full Text] [Related]
2. Correlations between DW-MRI and
Connor S; Sit C; Anjari M; Szyszko T; Dunn J; Pai I; Cook G; Goh V
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1360. PubMed ID: 33960739
[TBL] [Abstract][Full Text] [Related]
3. Comparison of diffusion-weighted MRI and [
Morakote W; Baratto L; Ramasamy SK; Adams LC; Liang T; Sarrami AH; Daldrup-Link HE
Eur Radiol; 2024 Jan; 34(1):643-653. PubMed ID: 37542653
[TBL] [Abstract][Full Text] [Related]
4. Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [
Azad GK; Taylor BP; Green A; Sandri I; Swampillai A; Harries M; Kristeleit H; Mansi J; Goh V; Cook GJR
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):821-830. PubMed ID: 30506455
[TBL] [Abstract][Full Text] [Related]
5. Ultra-early response assessment in lymphoma treatment: [
Mayerhoefer ME; Raderer M; Jaeger U; Staber P; Kiesewetter B; Senn D; Gallagher FA; Brindle K; Porpaczy E; Weber M; Berzaczy D; Simonitsch-Klupp I; Sillaber C; Skrabs C; Haug A
Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):931-940. PubMed ID: 29480328
[TBL] [Abstract][Full Text] [Related]
6. Exploratory radiomic features from integrated
Baiocco S; Sah BR; Mallia A; Kelly-Morland C; Neji R; Stirling JJ; Jeljeli S; Bevilacqua A; Cook GJR; Goh V
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1478-1484. PubMed ID: 30919055
[TBL] [Abstract][Full Text] [Related]
7. Relationships of body habitus and SUV indices with signal-to-noise ratio of hepatic (18)F-FDG PET.
Keramida G; Dunford A; Siddique M; Cook GJ; Peters AM
Eur J Radiol; 2016 May; 85(5):1012-5. PubMed ID: 27130064
[TBL] [Abstract][Full Text] [Related]
8. Comparison of whole-body DW-MRI with 2-[
Baratto L; Nyalakonda R; Theruvath AJ; Sarrami AH; Hawk KE; Rashidi A; Shen S; States L; Aboian M; Jeng M; Daldrup-Link HE
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1689-1698. PubMed ID: 36717409
[TBL] [Abstract][Full Text] [Related]
9. PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype.
Catalano OA; Horn GL; Signore A; Iannace C; Lepore M; Vangel M; Luongo A; Catalano M; Lehman C; Salvatore M; Soricelli A; Catana C; Mahmood U; Rosen BR
Br J Cancer; 2017 Mar; 116(7):893-902. PubMed ID: 28208155
[TBL] [Abstract][Full Text] [Related]
10. Changes in serial multiparametric MRI and FDG-PET/CT functional imaging during radiation therapy can predict treatment response in patients with head and neck cancer.
Trada Y; Keall P; Jameson M; Moses D; Lin P; Chlap P; Holloway L; Min M; Forstner D; Fowler A; Lee MT
Eur Radiol; 2023 Dec; 33(12):8788-8799. PubMed ID: 37405500
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of WB-DWI versus
Zhang B; Zhang L; Bian B; Lin F; Zhu Z; Wang J
Indian J Cancer; 2023; 60(3):303-309. PubMed ID: 37787189
[TBL] [Abstract][Full Text] [Related]
12. Benefits and challenges of
Luo ZH; Qi WL; Jin AF; Zeng QY
Clin Radiol; 2024 Jun; 79(6):428-435. PubMed ID: 38492999
[TBL] [Abstract][Full Text] [Related]
13. The added value of
Lv J; Yin H; Yu H; Shi H
Abdom Radiol (NY); 2023 Jul; 48(7):2331-2339. PubMed ID: 37119293
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor.
Zwezerijnen GJC; Eertink JJ; Ferrández MC; Wiegers SE; Burggraaff CN; Lugtenburg PJ; Heymans MW; de Vet HCW; Zijlstra JM; Boellaard R
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):486-493. PubMed ID: 36166080
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers from in vivo molecular imaging of breast cancer: pretreatment
Gallivanone F; Panzeri MM; Canevari C; Losio C; Gianolli L; De Cobelli F; Castiglioni I
MAGMA; 2017 Aug; 30(4):359-373. PubMed ID: 28246950
[TBL] [Abstract][Full Text] [Related]
16. Enhancing the clinical diagnosis of the acute and subacute phases of autoimmune encephalitis and predicting the risk factors: the potential advantages of 18F-FDG PET/CT.
Liu L; Lyu Z; Li H; Bai L; Wan Y; Li P
BMC Med Imaging; 2023 Nov; 23(1):193. PubMed ID: 37986052
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of
Cook GJR; Lovat E; Siddique M; Goh V; Ferner R; Warbey VS
Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1845-1852. PubMed ID: 28589254
[TBL] [Abstract][Full Text] [Related]
18. Correlation of the apparent diffusion coefficient with the standardized uptake value in meningioma of the skull plane using [68]Ga-DOTATOC PET/MRI.
Milosevic A; Styczen H; Haubold J; Kessler L; Grueneisen J; Li Y; Weber M; Fendler WP; Morawitz J; Damman P; Wrede K; Kebir S; Glas M; Guberina M; Blau T; Schaarschmidt BM; Deuschl C
Nucl Med Commun; 2023 Dec; 44(12):1106-1113. PubMed ID: 37823259
[TBL] [Abstract][Full Text] [Related]
19. Mitigating SUV uncertainties using total body PET imaging.
Smith CLC; Zwezerijnen GJC; den Hollander ME; Weijland J; Yaqub M; Boellaard R
Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1070-1078. PubMed ID: 37953391
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Three Imaging Methods to Quantify Key Events in Pelvic Bone Metastasis.
Lee H; Ahn TR; Hwang KH; Lee SW
Cancers (Basel); 2024 Jan; 16(1):. PubMed ID: 38201641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]